Articles by Mikkel Stern-Peltz
Foresight invests £4m in Itad
Deal sees two non-exec directors and new chair join Itad
Total Capital sells Arthouse to NorthEdge
Exit marks full realisation of Total Capital fund, which returns 1.9x
Northzone’s mCash sells Norwegian operations
VC will not realise any value or receive cash from sale
Palamon appoints Ireland as associate principal
Ireland joins following completion of her Harvard MBA
Accent carves out Nordic Traction
Carve-out sees partial exit for parent owner Segulah
Altor sells 14% Dustin stake
Partial exit is likely worth around SEK 600m for GP
Mid Europa increases Walmark stake to 100%
Stake increase follows two bolt-ons in 2015
Ratos’s Bisnode acquires AIS Nordic for SEK 65m
Swedish listed GP will contribute SEK 45m in equity
Upcoming IPO to value Advent’s Equiniti at up to £600m
Offer price range set between 165-200 pence per share
Accel leads €18m series-B for Doctolib
Series-B brings total funding raised to €23m
Via Venture acquires EnviDan
Buyout comes as part of ongoing succession plans
Segulah sells Etraveli to ProSieben Travel for SEK 2.2bn
Deal is second exit for GP in 2015
Goldman Sachs' Hastings lists in £1.1bn IPO
Company raises £210m in proceeds
Change Capital makes 2.7x on £98.4m Macduff exit
GP's second fund exits 50% stake after nearly five years
Origination: perfecting processes
Part two of our Origination Series looks at processes and intermediaries
Catapult makes 5.2x on Oxford Cryosystems exit
Company's management buys back Catapult's stake
Hellman & Friedman acquires Bain stake in Securitas Direct
Securitas Direct Verisure becomes largest ever standalone investment for GP
Advent’s Equiniti to raise £390m in London listing
Market cap likely to be around £1bn
CapMan exits Swereco in SEK 250m deal
Equity price is SEK 250m, CapMan sells 37.5% stake
Mid Europa’s Walmark acquires Valosun
Mid Europa took 50% stake in Walmark in July 2012
Charterhouse X holds €1.5bn first close
Fund targeting €3bn with €3.5bn hard-cap
Axcel merges EG and Silkeborg Data
Silkeborg Data's debt will be refinanced as part of the deal
Wales Life Sciences Fund leads €12m series-B for Apitope
Cash will fund drug development and move to Wales
Deal in Focus: Polaris’s Mols-Linien deal clears stormy weather
Polaris has had to navigate choppy water with Mols-Linien, but calmer waters await